Panel Upholds Pharma Class Suit Dismissal
Shifting fraud theories helped sink an attempted securities class action appeal by former employees of the pharmaceutical company Covis.
This premium content is reserved for New York Law Journal subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now